News/ R&D/ UK & Europe Good news for GSK’s next generation asthma drug Andrew McConaghie asthma, Breo Ellipta, COPD, GSK, respiratory, Revlar Ellipta 0 Comment Results mean patients could switch to once-daily inhaler use Share X Good news for GSK’s next generation asthma drug https://pharmaphorum.com/news/study-brings-good-news-gsks-next-generation-asthma-drug/